Новини медицини

Псориаз и ассоциированные психические расстройства. Список литературы

25 марта 2018
Комментировать
25 Просмотров
7 минут на прочтение

Список литературы:

  1. Hunter HJ, Griffiths CE, Kleyn CE. Does psychosocial stress play a role in the exacerbation of psoriasis? Br J Dermatol. 2013;169:965–974.2. Kumar S, K
  2. Аchhawha D, Das Koolwal G, et al. Psychiatric morbidity in psoriasis patients: a pilot study. Indian J Dermatol Venereol Leprol. 2011;77:625.
  3. Rieder E, Tausk F. Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments. Int J Dermatol. 2012;51:12–26.
  4. Moller AH, Erntoft S, Vinding GR, Jemec GB. A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-5D-derived utility values. Patient Relat Outcome Meas. 2015;6:167–177.
  5. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med. 2009;151 W65-94.
  6. Haynes RB. Of studies, syntheses, synopses, summaries, and systems: the “5S” evolution of information services for evidence-based healthcare decisions. Evid Based Med. 2006;11:162–164.
  7. American Psychiatric Association; 5th ed. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 2013.
  8. Gaikwad R, Deshpande S, Raje S, et al. Evaluation of functional impairment in psoriasis. Indian J Dermatol Venereol Leprol. 2006;72:37–40.
  9. Shutty BG, West C, Huang KE, et al. Sleep disturbances in psoriasis. Dermatol Online J. 2013;19:1.
  10. Jankovic S, Raznatović M, Marinkovic J, et al. Relevance of psychosomatic factors in psoriasis: a case-control study. Acta Derm Venereol. 2009;89:364–368.
  11. Basavaraj KH, Navya MA, Rashmi R. Stress and quality of life in psoriasis: an update. Int J Dermatol. 2011;50:783–792.
  12. Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively influencing the well-being of psoriatic patients. Acta Derm Venereol. 2010;90:257–263.
  13. Heller MM, Lee ES, Koo JY. Stress as an influencing factor in psoriasis. Skin Therapy Lett. 2011;16:1–4.
  14. Palijan TZ, Kovacevic D, Koic E, et al. The impact of psoriasis on the quality of life and psychological characteristics of persons suffering from psoriasis. Coll Antropol. 2011;35(Suppl 2):81–85.
  15. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14:267–271.
  16. Mizara A, Papadopoulos L, McBride SR. Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease. Br J Dermatol. 2012;166:986–993.
  17. Evers AW, Verhoeven EW, Kraaimaat FW, et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol. 2010;163:986–991.
  18. Moynihan J, Rieder E, Tausk F. Psychoneuroimmunology: the example of psoriasis. G Ital Dermatol Venereol. 2010;145:221–228.
  19. Thorslund K, Amatya B, Dufva AE, Nordlind K. The expression of serotonin transporter protein correlates with the severity of psoriasis and chronic stress. Arch Dermatol Res. 2013;305:99–104.
  20. Schmitt J, Wozel G, Garzarolli M, et al. Effectiveness of interdisciplinary vs. dermatological care of moderate-to-severe psoriasis: a pragmatic randomised controlled trial. Acta Derm Venereol. 2014;94:192–197.
  21. Hrehorów E, Salomon J, Matusiak L, et al. Patients with psoriasis feel stigmatized. Acta Derm Venereol. 2012;92:67–72.
  22. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol. 2004;45:155–159.
  23. Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol. 2003;4:833–842.
  24. Akay A, Pekcanlar A, Bozdag KE, et al. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol. 2002;16:347–352.
  25. Hayes J, Koo J. Depression and acitretin: a true association or a class labeling? J Drugs Dermatol. 2011;10:409–412.
  26. Kurizky PS, Mota LM. Sexual dysfunction in patients with psoriasis and psoriatic arthritis— a systematic review. Rev Bras Reumatol. 2012;52:943–948.
  27. McAleer MA, Mason DL, Cunningham S, et al. Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress. Br J Dermatol. 2011;164:1256–1261.
  28. Barankin B, DeKoven J. Psychosocial effect of common skin diseases. Can Fam Physician. 2002;48:712–716.
  29. Gupta MA. Psychosocial aspects of common skin diseases. Can Fam Physician. 2002;48 660-662, 668-670.
  30. Bouguéon K, Misery L. Depression and psoriasis. Ann Dermatol Venereol. 2008;135(Suppl 4):S254–258.
  31. Kirby B. The psych and inflammatory skin disease. Br J Dermatol. 2012;166:911.
  32. Moreno-Giménez JC, Jiménez-Puya R, Galán-Gutiérrez M. Comorbidities in psoriasis. Actas Dermosifiliogr. 2010;101(Suppl 1):55–61.
  33. Freire M, Rodriguez J, Möller I, et al. Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics. Reumatol Clin. 2011;7:20–26.
  34. Kotrulja L, Tadinac M, Joki-Begi NA, Gregurek R. A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients. Acta Derm Venereol. 2010;90:251–256.
  35. Poot F, Antoine E, Gravellier M, et al. A case-control study on family dysfunction in patients with alopecia areata, psoriasis and atopic dermatitis. Acta Derm Venereol. 2011;91:415–421.
  36. Martín B, Sánchez-Carazo JL, Pérez-Ferriols A, et al. Clinical experience with etanercept in the treatment of psoriasis. Actas Dermosifiliogr. 2008;99:540–545.
  37. Gowda S, Goldblum OM, McCall WV, Feldman SR. Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol. 2010;63:114–123.
  38. Kannan S, Heller MM, Lee ES, Koo JY. The role of tumor necrosis factor-alpha and other cytokines in depression: what dermatologists should know. J Dermatolog Treat. 2013;24:148–152.
  39. Hagforsen E, Michaëlsson K, Lundgren E, et al. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study. Acta Derm Venereol. 2005;85:225–232.
  40. Sandyk R, Pardeshi R. Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin. Int J Neurosci. 1990;50:215–221.
  41. Kaufman KR. Etanercept, anticytokines and mania. Int Clin Psychopharmacol. 2005;20:239–241.
  42. Demirhan O, Demirbek B, Tunc E, et al. Identification of chromosome abnormalities in screening of a family with manic depression and psoriasis: predisposition to aneuploidy. Asian J Psychiatr. 2012;5:169–174.
  43. Crosta ML, Caldarola G, Fraietta S, et al. Psychopathology and eating disorders in patients with psoriasis. G Ital Dermatol Venereol. 2014;149:355–361.
  44. Rubino IA, Zanna V. Further comments on psoriasis and personality disorders. Psychol Rep. 1996;79(3 Pt 2):1248–1250.
  45. Mazzetti M, Mozzetta A, Soavi GC, et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol Suppl (Stockh). 1994;186:62–64.
  46. Yang YW, Lin HC. Increased risk of psoriasis among patients with schizophrenia: a nationwide population-based study. Br J Dermatol. 2012;166:899–900.
  47. Miyaoka T, Seno H, Inagaki T, et al. Schizophrenia associated with psoriasis vulgaris: three case reports. Schizophr Res. 2000;41:383–386.
  48. Shimamoto Y, Shimamoto H. Annular pustular psoriasis associated with affective psychosis. Cutis. 1990;45:439–442.
  49. Latini A, Carducci M. Psoriasis during therapy with olanzapine. Eur J Dermatol. 2003;13:404–405.
  50. Ascari-Raccagni A, Baldari U, Rossi E, Alessandrini F. Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy. J Eur Acad Dermatol Venereol. 2000;14:315–316.
  51. Di Nuzzo S, Zanni M, De Panfilis G. Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A but not with etanercept. J Drugs Dermatol. 2007;6:1046–1047.
  52. Callis Duffin K, Wong B, Horn EJ, Krueger GG. Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol. 2009;60:604–608.
  53. Picardi A, Pasquini P, Cattaruzza MS, et al. Only limited support for a role of psychosomatic factors in psoriasis. Results from a case-control study. J Psychosom Res. 2003;55:189–196.
  54. Gupta MA, Gupta AK, Ellis CN, Voorhees JJ. Some psychosomatic aspects of psoriasis. Adv Dermatol. 1990;5:21–30. discussion 31.
  55. Poikolainen K, Reunala T, Karvonen J, et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 1990;300:780–783.
  56. Bahmer JA, Kuhl J, Bahmer FA. How do personality systems interact in patients with psoriasis, atopic dermatitis and urticaria? Acta Derm Venereol. 2007;87:317–324.
  57. Meyer N, Viraben R, Paul C. Addictions and psoriasis: an example of the dermatologist’s implication in preventive medicine? Ann Dermatol Venereol. 2008;135(Suppl 4):S259–262.
  58. Dellavalle RP, Johnson KR. Do smoking, obesity, and stress cause psoriasis? J Invest Dermatol. 2005;125:vi–vii.
  59. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125:61–67.
  60. Adamzik K, McAleer MA, Kirby B. Alcohol and psoriasis: sobering thoughts. Clin Exp Dermatol. 2013;38:819–822.
  61. Dediol I, Buljan M, Buljan D, et al. Association of psoriasis and alcoholism: psychodermatological issue. Psychiatr Danub. 2009;21:9–13.
  62. Tasliyurt T, Bilir Y, Sahin S, et al. Erectile dysfunction in patients with psoriasis: potential impact of the metabolic syndrome. Eur Rev Med Pharmacol Sci. 2014;18:581–586.
Теги

Комментировать

Нажмите для комментария

    Ми на Facebook

    Медпросвита

    Найпопулярніше

    Вибір редакції